MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in MoonLake Immunotherapeutics as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −18 vs. Q4 2021
- Shares held
- 11.6M
- +141.4K (+1.2%) vs. Q4 2021
- Total value
- $123.4M
- +$10.6M (+9.4%) vs. Q4 2021
- New holders
- 7
- 8 more added
- Sold out
- 25
- 2 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Street LLC | 801 | $9.00K | 0.00% | +801 | New |
| UBS Group AG | 1,692 | $19.0K | 0.00% | +1,692 | New |
| Ergoteles LLC | 14,613 | $162.0K | 0.01% | +14,613 | New |
| Nomura Holdings Inc | 22,733 | $239.0K | 0.00% | 00.0% | Unchanged |
| Meridian Wealth Management, LLC | 42,094 | $467.0K | 0.05% | 00.0% | Unchanged |
| Omers Administration Corp | 46,247 | $513.0K | 0.01% | +46,247 | New |
| Fir Tree Capital Management LP | 61,866 | $619.0K | 0.02% | +61,866 | New |
| Picton Mahoney Asset Management | 70,000 | $700.0K | 0.03% | 00.0% | Unchanged |
| Jane Street Group, LLC | 65,437 | $726.0K | 0.00% | +65,437 | New |
| Consonance Capital Management LP | 137,000 | $1.52M | 2.58% | −13,000−8.7% | Reduced |
| Millennium Management LLC | 148,225 | $1.65M | 0.00% | +92,490+165.9% | Added |
| Iron Park Capital Partners, LP | 179,434 | $1.79M | 1.51% | +117,218+188.4% | Added |
| Weiss Asset Management LP | 177,510 | $1.97M | 0.04% | +162,510+1,083.4% | Added |
| EcoR1 Capital, LLC | 200,000 | $2.22M | 0.07% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 250,000 | $2.77M | 0.10% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 337,021 | $3.74M | 0.00% | 00.0% | Unchanged |
| Avidity Partners Management LP | 400,000 | $4.44M | 0.10% | 00.0% | Unchanged |
| Falcon Edge Capital, LP | 448,882 | $4.49M | 0.40% | +141,047+45.8% | Added |
| Beryl Capital Management LLC | 459,243 | $5.10M | 0.31% | +459,243 | New |
| Price T Rowe Associates Inc | 566,191 | $6.29M | 0.00% | −180,671−24.2% | Reduced |
| Staley Capital Advisers Inc | 580,000 | $6.35M | 0.32% | 00.0% | Unchanged |
| Marshall Wace, LLP | 653,872 | $7.26M | 0.02% | +120,968+22.7% | Added |
| Citadel Advisors LLC | 698,896 | $7.76M | 0.01% | +12,959+1.9% | Added |
| 683 Capital Management, LLC | 790,000 | $7.90M | 0.47% | +200,000+33.9% | Added |
| BlackRock Inc. | 741,906 | $8.24M | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1,193,000 | $13.2M | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 3,280,000 | $33.3M | 2.55% | +2,850,000+662.8% | Added |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,011,589−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −371,849−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −320,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Tenor Capital Management Co., L.P. | 0 | $0 | 0.00% | −201,152−100.0% | Sold out |
| Cowen Investment Management LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| BlueCrest Capital Management Ltd | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −131,823−100.0% | Sold out |
| Omni Event Management Ltd | 0 | $0 | 0.00% | −100,913−100.0% | Sold out |
| Cohen & Co Financial Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −78,308−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −50,106−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −44,766−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −37,385−100.0% | Sold out |
| Radcliffe Capital Management, L.P. | 0 | $0 | 0.00% | −25,130−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −25,200−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −16,009−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,258−100.0% | Sold out |
| Rpo LLC | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −13,449−100.0% | Sold out |
| Antara Capital LP | 0 | $0 | 0.00% | −6,246−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −193−100.0% | Sold out |